ClinicalTrials.govpublic full text
Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis
gastric cancer stage iv, peritoneal metastases, gastric cancer, peritoneal metastasis, paclitaxel, sintilimab, chemotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 852914
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.